Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Zabalza

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Molecular Plant|March 16, 2012
Comparative transcriptomic analysis of salt adaptation in roots of contrasting Medicago truncatula genotypesOns Zahaf, Sandrine Blanchet, Axel de Zélicourt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 7, 2022
Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health SolutionsJeffrey A Cohen, Robert A Bermel, Cynthia I Grossman, et al.
Acta Neurologica Scandinavica|July 31, 2018
Underdiagnosis of Unilateral Spatial Neglect in stroke unitAlbert Puig-Pijoan, Eva Giralt-Steinhauer, Ana Zabalza de Torres, et al.
Journal of Neurology|October 1, 2021
Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing-remitting multiple sclerosis patientsJordi Río, Àlex Rovira, Claudio Gasperini, et al.
Journal of Neurology|November 20, 2021
Correction to: Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing-remitting multiple sclerosis patientsJordi Río, Àlex Rovira, Claudio Gasperini, et al.
Neurology|December 17, 2020
Optic Nerve Topography in Multiple Sclerosis Diagnosis: The Utility of Visual Evoked PotentialsAngela Vidal-Jordana, Alex Rovira, Georgina Arrambide, et al.
JAMA Neurology|December 19, 2022
Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple SclerosisCarmen Tur, Pere Carbonell-Mirabent, Álvaro Cobo-Calvo, et al.
European Journal of Neurology|February 20, 2021
Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onsetSusana Otero-Romero, Luciana Midaglia, Pere Carbonell-Mirabent, et al.
Neurology|September 15, 2021
Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated SyndromeMar Tintore, Alvaro Cobo-Calvo, Pere Carbonell, et al.
European Journal of Neurology|December 19, 2020
COVID-19 in multiple sclerosis patients: susceptibility, severity risk factors and serological responseAna Zabalza, Simón Cárdenas-Robledo, Paula Tagliani, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Molecular Plant|March 16, 2012
Comparative transcriptomic analysis of salt adaptation in roots of contrasting Medicago truncatula genotypesOns Zahaf, Sandrine Blanchet, Axel de Zélicourt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 7, 2022
Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health SolutionsJeffrey A Cohen, Robert A Bermel, Cynthia I Grossman, et al.
Acta Neurologica Scandinavica|July 31, 2018
Underdiagnosis of Unilateral Spatial Neglect in stroke unitAlbert Puig-Pijoan, Eva Giralt-Steinhauer, Ana Zabalza de Torres, et al.
Journal of Neurology|October 1, 2021
Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing-remitting multiple sclerosis patientsJordi Río, Àlex Rovira, Claudio Gasperini, et al.
Journal of Neurology|November 20, 2021
Correction to: Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing-remitting multiple sclerosis patientsJordi Río, Àlex Rovira, Claudio Gasperini, et al.
Neurology|December 17, 2020
Optic Nerve Topography in Multiple Sclerosis Diagnosis: The Utility of Visual Evoked PotentialsAngela Vidal-Jordana, Alex Rovira, Georgina Arrambide, et al.
JAMA Neurology|December 19, 2022
Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple SclerosisCarmen Tur, Pere Carbonell-Mirabent, Álvaro Cobo-Calvo, et al.
European Journal of Neurology|February 20, 2021
Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onsetSusana Otero-Romero, Luciana Midaglia, Pere Carbonell-Mirabent, et al.
Neurology|September 15, 2021
Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated SyndromeMar Tintore, Alvaro Cobo-Calvo, Pere Carbonell, et al.
European Journal of Neurology|December 19, 2020
COVID-19 in multiple sclerosis patients: susceptibility, severity risk factors and serological responseAna Zabalza, Simón Cárdenas-Robledo, Paula Tagliani, et al.
Pageof 11